OHLCX Market Research
Delayed

LABU

LABU, or Direxion Daily S&P Biotech Bull 3X Shares, is an exchange-traded fund (ETF) designed to provide three times the daily return of the S&P Biotechnology Select Industry Index. It aims to deliver 3x the daily performance of the underlying index.

−13.18 (−7.03%) Nov 20, 2026 19:35 ET Delayed
Open
185.00
High
192.79
Low
170.76
Prev close
187.58
Volume
378K
Avg vol 10
367K

Today · Market closed · opens Mon 9:30 AM

Price

LABU chart

Updating chart…

Scroll or pinch to zoom, drag to pan, or use the buttons on the chart. About the price history

Signals

Technical analysis

Daily bars · last bar Nov 20, 2026 · close 174.40

Strong sellNeutralStrong buy
Sell
score −0.33 · 18 signalling
2Buy
8Neutral
8Sell

Leaning sell. 8 of 18 signals point down against 2 up, carried by momentum and trend. Volatility leans buy. Volume is mostly neutral. Stochastic, Stoch RSI, Williams %R and CCI sit in oversold territory. Trend strength is weak (ADX 16).

How to read this →

Trend

MACD 12, 26, 9
Below signal line and zero
MACD −14.24 · Signal −8.84 · Hist −5.40
Sell
ADX 14
Weak trend, −DI ahead
ADX 15.88 · +DI 15.50 · −DI 29.10
Neutral
Parabolic SAR 0.02, 0.2
Above price, 60.83 over the close
235.23
Sell
Ichimoku 9, 26, 52
Price below cloud, conversion below base
Conv 210.31 · Base 219.51 · A 239.99 · B 272.62
Sell

Momentum

RSI 14
Below midpoint, not oversold
35.31
Neutral
Stoch 14, 3
Oversold, %K still below %D
%K 3.74 · %D 5.64
Neutral
Stoch RSI 14, 14, 3, 3
Oversold, %K level with %D
%K 0.00 · %D 0.00
Neutral
Williams %R 14
Oversold zone, falling
−96.26
Neutral
CCI 14
Below −100, still falling
−136.72
Neutral
MFI 14
Below midpoint, not oversold
37.31
Neutral
ROC 12
Price down 33.09% over 12 bars
−33.09%
Sell
AO 5, 35
Below zero and falling
−30.96
Sell
TRIX 18
Below zero
−0.446
Sell
KST 10/15/20/30, 3
Below its signal line
KST −101.80 · Signal −84.60
Sell

Volatility

Bollinger 20, 2
Lower half, %b 0.00
Up 274.09 · Mid 224.24 · Low 174.39
Neutral
Keltner 20, 10, 1.5
Below the lower channel
Up 247.77 · Mid 215.28 · Low 182.79
Buy

Volume

VWAP 345-bar
Close 18.1% above VWAP
147.63
Buy
Force Index 1
Negative, sellers in control
−5.0M
Sell
ATR
21.80
12.50% of close
A/D Line
14.7M
cumulative
OBV
23.6M
cumulative
Volume Profile
58.35 – 78.61
POC · bull 32.0M · bear 34.7M · 48 / 52
Risk and return

Performance

Daily returns for Jan 1, 2026 – Nov 22, 2026 (YTD). About the returns · About the risk figures

1 month return

-24.95%

Change in value over the past month.

3 month return

-44.22%

Change in value over the last three months.

Max drawdown

49.64%

Largest fall from a peak to the low that followed.

Standard deviation

92.86%

How far daily returns stray from their average, annualised.

Sharpe ratio

0.57

Return above the risk-free rate per unit of volatility.

Calmar ratio

1.07

Annualised return against the maximum drawdown.

About

LABU summary

Loading summary…

Questions

LABU, answered

Can LABU be used in a retirement account?

Yes, LABU can be held in retirement accounts such as IRAs or 401(k)s. However, due to its high-risk, leveraged nature, it’s crucial to assess how it fits within your overall investment strategy and risk tolerance.

How often does LABU distribute dividends?

LABU typically distributes dividends on a quarterly basis. These dividends are derived from income produced by the underlying securities, although leveraged ETFs often have lower yields compared to non-leveraged funds.

How can I invest in LABU?

Investors can purchase shares of LABU through a brokerage account. It is traded on major stock exchanges under the ticker symbol "LABU" and can be bought and sold like other stocks and ETFs.

How does LABU’s performance compare to the S&P Biotechnology Select Industry Index?

LABU aims to deliver three times the daily return of the S&P Biotechnology Select Industry Index. Due to its leveraged nature, its performance can significantly deviate from the index over periods longer than one day due to compounding effects and daily rebalancing.

How does LABU handle index rebalancing or changes?

LABU rebalances its holdings daily to maintain its 3x leverage ratio relative to the S&P Biotechnology Select Industry Index. This daily rebalancing aims to achieve the 3x daily performance, though it can lead to performance deviations over longer periods due to the effects of compounding.

What are the key performance metrics for LABU?

Key performance metrics for LABU include its net asset value (NAV), expense ratio, daily return performance, and leverage ratio. LABU targets 3x the daily performance of the S&P Biotechnology Select Industry Index.

What are some similar ETFs to LABU?

Similar ETFs to LABU include: BIB (ProShares Ultra Biotech), which seeks to provide twice the daily performance of the S&P Biotechnology Select Industry Index; XBI (SPDR S&P Biotech ETF), which tracks the S&P Biotechnology Select Industry Index and provides broad exposure to the biotech sector; and IBB (iShares Nasdaq Biotechnology ETF), which tracks the Nasdaq Biotechnology Index and offers exposure to biotechnology and pharmaceutical companies.

How does LABU’s use of leverage impact its performance?

LABU uses leverage to amplify its exposure to the biotechnology sector, targeting 3x the daily performance of the S&P Biotechnology Select Industry Index. Leverage can result in significant fluctuations in performance, especially over periods longer than one day due to compounding effects.

What is the expense ratio of LABU?

LABU has an expense ratio of approximately 1.04%. This fee reflects the cost of managing the fund, including administrative and operational expenses, and is expressed as a percentage of the fund’s average net assets.

What is the historical performance of LABU?

Historical performance data for LABU includes past returns, NAV, and volatility. It’s important for investors to review performance charts and reports to understand how LABU has tracked its leveraged objective over different time periods.

Reveal Your LABU Trading Now

Take control of your trading with OHLCX. Our platform offers unparalleled analysis and technical support for LABU, designed to enhance your market performance. Start optimizing your trades today and experience the difference with our expert tools!

Unlock Full Potential Now

Disclaimers

The information displayed on this site is sourced from third-party providers and is believed to be reliable. OHLCX has not independently verified this data and does not guarantee its accuracy. Content is for educational and informational purposes only and is not financial or investment advice.

With any investment, your capital is at risk. Past performance is no guarantee of future results. Consult your provider's terms and privacy policies where applicable.

Prices, charts and every figure derived from them are delayed by at least 15 minutes and are provided for information only; we do not guarantee their accuracy or timeliness.

Securities products are: Not FDIC insured · Not bank guaranteed · May lose value

Trademarks and logos are the property of their respective owners and do not represent endorsements of any kind.